Bryn Mawr Trust Advisors LLC reduced its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 2.7% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 120,648 shares of the company’s stock after selling 3,349 shares during the quarter. Bryn Mawr Trust Advisors LLC’s holdings in Procter & Gamble were worth $17,528,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Ellis Investment Partners LLC lifted its position in Procter & Gamble by 0.7% during the 3rd quarter. Ellis Investment Partners LLC now owns 8,816 shares of the company’s stock worth $1,281,000 after acquiring an additional 64 shares during the last quarter. Clark Wealth Partners boosted its holdings in Procter & Gamble by 20.6% during the third quarter. Clark Wealth Partners now owns 387 shares of the company’s stock valued at $56,000 after acquiring an additional 66 shares during the period. Kuhn & Co Investment Counsel boosted its holdings in Procter & Gamble by 1.0% during the third quarter. Kuhn & Co Investment Counsel now owns 6,555 shares of the company’s stock valued at $952,000 after acquiring an additional 66 shares during the period. Whelan Financial boosted its holdings in Procter & Gamble by 1.9% during the third quarter. Whelan Financial now owns 3,689 shares of the company’s stock valued at $536,000 after acquiring an additional 68 shares during the period. Finally, Midwest Professional Planners LTD. grew its position in shares of Procter & Gamble by 2.6% in the second quarter. Midwest Professional Planners LTD. now owns 2,799 shares of the company’s stock valued at $410,000 after purchasing an additional 70 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: P&G has raised its dividend for 70 consecutive years. Its quarterly payout is about $1.09 per share, equivalent to a roughly 2.6% yield, supporting the stock’s appeal to income-focused investors. Article: P&G dividend history and yield
- Positive Sentiment: Recent coverage points to investor interest in consumer-staples stocks as technology shares weaken. P&G may benefit from its defensive profile and dividend reputation. Article: Consumer staples rotation
- Neutral Sentiment: Zacks Research made mixed earnings-estimate changes: it lowered several forecasts for 2027 and 2028, while modestly raising some later-period estimates. The mixed revisions offer no clear overall change in the longer-term outlook. Procter & Gamble analyst estimates
- Neutral Sentiment: Management will discuss strategy and P&G’s long-term transformation at an Investor Day webcast on November 19; investors may look for updates on growth and execution. Article: P&G Investor Day webcast
- Negative Sentiment: CFO Andre Schulten sold 33,624 shares for about $5.55 million, reducing his direct stake by roughly 34%. The sale may concern investors, although insider transactions alone do not establish a change in the company’s prospects. Article: CFO share sale
Procter & Gamble Price Performance
Shares of Procter & Gamble stock opened at $165.31 on Monday. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $170.52. The firm has a fifty day moving average price of $152.01 and a two-hundred day moving average price of $149.43. The company has a market cap of $383.15 billion, a PE ratio of 24.90, a price-to-earnings-growth ratio of 4.07 and a beta of 0.36.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.11. The company had revenue of $23.28 billion for the quarter, compared to the consensus estimate of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The business’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.99 EPS. Analysts expect that Procter & Gamble Company will post 6.99 EPS for the current year.
Procter & Gamble Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a yield of 2.6%. Procter & Gamble’s dividend payout ratio (DPR) is 65.51%.
Analysts Set New Price Targets
A number of research firms have recently commented on PG. Royal Bank Of Canada set a $169.00 price objective on Procter & Gamble in a research note on Friday, October 23rd. UBS Group set a $166.00 target price on Procter & Gamble in a research note on Friday, October 23rd. Citigroup raised their target price on Procter & Gamble from $180.00 to $187.00 and gave the company a “buy” rating in a report on Friday, October 23rd. TD Cowen lifted their price target on Procter & Gamble from $150.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, October 23rd. Finally, DZ Bank lowered Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 27th. Fifteen investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $170.57.
Read Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling at Procter & Gamble
In related news, CFO Andre Schulten sold 33,624 shares of the business’s stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $165.00, for a total transaction of $5,547,960.00. Following the transaction, the chief financial officer directly owned 65,618 shares in the company, valued at $10,826,970. The trade was a 33.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Paul Gama sold 2,894 shares of the company’s stock in a transaction that occurred on Friday, October 30th. The shares were sold at an average price of $165.00, for a total value of $477,510.00. Following the completion of the transaction, the chief executive officer directly owned 43,899 shares of the company’s stock, valued at approximately $7,243,335. This trade represents a 6.18% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 161,709 shares of company stock valued at $26,244,058 over the last quarter. Company insiders own 0.23% of the company’s stock.
About Procter & Gamble
Featured Articles
- Five stocks we like better than Procter & Gamble
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
